A $225,000 grant to pilot in the Philippines and China a life-saving neonatal technology that screens new-born babies for infections like pneumonia and congenital heart defects – at less than 10% of the cost of traditional screening.
Commitment to evaluation.
The Newborn Foundation is committed to evaluating whether pulse oximetry screening really is a cost effective way to save lives at birth in countries like the Philippines and China.
Track record of public sector scaling.
The Newborn Foundation has already successfully worked to make pulse oximetry screening for newborns standard practice in the U.S. They are collaborating closely with public hospitals in China and the Philippines, and developing strong relationships with key public health policy makers to scale up pulse oximetry if the results of the pilot study are positive.Apply for funding